Virax Biolabs Group Ltd (VRAX) Shareholders’ equity 2021–2025
Virax Biolabs Group Ltd (VRAX) shareholders’ equity at each fiscal year-end, per SEC filings.
$5.7MFY2025 · since FY2021: -$650,682 → $5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.7M | +6.1% |
| FY2024 | $5.4M | -41.2% |
| FY2023 | $9.1M | +1036.4% |
| FY2022 | -$974,578 | -49.8% |
| FY2021 | -$650,682 | — |
Source: SEC XBRL filings · For reference only · Not investment advice